CNTN logo

CANTON STRATEGIC HOLDINGS IN

CNTNNASDAQ
🏆 #3694 by market capUS Equity
$931.41▲ $35.30 (+3.79%)
Simulated price
🔔
Track CNTN
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 3.8%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$207M
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
100.0%
High
💵FCF Margin
-1482.1%
Thin
⚖️P/S Ratio
138.7x
Expensive
Otter Score
60
Fair
No chart data available for CNTN.

Trading Snapshot

Day Range
$920.56 – $939.89
52-Week Range
$1.75 – $6.89
Volume
$5.02B
Avg Volume
$5.90B
Shares Outstanding
77.1M
Next Earnings
Dec 5, 2026

Fundamentals Snapshot

Annual Revenue
$1M
Last Q Revenue
$392,739
P/E Ratio
-1.7
P/S Ratio
138.7x
EPS (TTM)
$-0.45
Dividend Yield
0.00%

Why Investors Own CNTN

  • ✓High-growth profile — revenue up +39.7% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 29% gross margin and 14% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

CNTN logo

CANTON STRATEGIC HOLDINGS IN

CNTN
Financial Trends
Revenue (TTM)The total money the company brought in from sales, before subtracting any costs.
$1M▲ +45.8% YoY
Gross Margin (TTM)Of every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
29.4%▲ +3.5% YoY
Operating Income (TTM)Profit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$379,948▲ +45.8% YoY
Free Cash Flow (TTM)Cash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$213,908▲ +45.8% YoY
StockOtter · stockotter.space

About CANTON STRATEGIC HOLDINGS IN

Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas. The company is committed to promoting the institutional integration of blockchain technology and fostering the digitization of financial markets, primarily by leveraging Canton Coin and offering support to the Canton network. In addition to its blockchain initiatives, the company is also deeply involved in pharmaceutical research and development. Its pipeline includes GV104, a buccal film technology designed to address respiratory and/or nervous system depression in military personnel and chemical incident responders, which has already finished its Phase 1 trial. Another significant project is GV023, an oral version of infliximab, engineered to resolve the key inconvenience of the standard intravenous treatment by eliminating the need for recurring infusions. Established in 2017, Canton Strategic Holdings Inc. is headquartered in Red Bank, New Jersey.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
60/100

Analyst Price Target

ⓘ
Average Target
$1,236.86
▲ +32.8% Upside
High Target$1,350.86
Low Target$1,000.78
Based on 34 analysts

Latest News & Updates

🚀
Reuters·2h ago

CANTON STRATEGIC HOLDINGS IN tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Barron’s·5h ago

Analysts lift CNTN price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
CNBC·1d ago

CANTON STRATEGIC HOLDINGS IN announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.